Mature miRNA ID from article | hsa-miR-21 |
miRBase ID | hsa-miR-21-5p |
miRBase Accession | MIMAT0000076 |
miRBase family | mir-21 |
Organism | Homo sapiens |
1 | ||
---|---|---|
First author | Taylor Dd et al. | |
Journal | Gynecol Oncol.110(1):13-21. | |
Title | Microrna signatures of tumor-derived exosomes as diagnostic biomarkers of ovarian cancer. | |
PubMed ID | 18589210 | |
Year of publication | 2008 | |
Potential biomarker role defined in the article | unknown | |
exRNA form | exosome | |
Sample | serum | |
Sample source | ts | |
Diseases, cell lines or normal status | papillary adenocarcinoma of ovary | |
Expression | - | |
Drug | - | |
Methods | 467microrna array | |
Experiment Description/Results | Microrna signatures of tumor-derived exosomes as diagnostic biomarkers of ovarian cancer. | |
Data imported from external databases? | Yes, ![]() |
2 | ||
---|---|---|
First author | Mitchell Ps et al. | |
Journal | Pnas 105(30):10513-8 | |
Title | Circulating micrornas as stable blood-based markers for cancer detection. | |
PubMed ID | 18663219 | |
Year of publication | 2008 | |
Potential biomarker role defined in the article | unknown | |
exRNA form | circulating | |
Sample | plasma | |
Sample source | - | |
Diseases, cell lines or normal status | normal | |
Expression | - | |
Drug | - | |
Methods | Taqman low-density array qrt-pcr | |
Experiment Description/Results | Mirnas are present in human plasma in a remarkably stable form that is protected from endogenous rnase activity. | |
Data imported from external databases? | No |
3 | ||
---|---|---|
First author | Hunter Mp et al. | |
Journal | Plos One. 3(11):e3694. | |
Title | Detection of microrna expression in human peripheral blood microvesicles. | |
PubMed ID | 19002258 | |
Year of publication | 2008 | |
Potential biomarker role defined in the article | unknown | |
exRNA form | exosome | |
Sample | plasma | |
Sample source | - | |
Diseases, cell lines or normal status | normal | |
Expression | down | |
Drug | - | |
Methods | Trizol (invitrogen, carlsbad, ca)|capillary electrophoresis on an agilent 2100 bioanalyzer (agilent technologies, inc, santa clara, ca)|real-time pcr using an applied biosystems 7900ht real-time pcr instrument|bd aria flow cytometer (bd biosciences) | |
Experiment Description/Results | Microvesicles were isolated from the plasma of normal healthy individuals. RNA was isolated from both the microvesicles and matched mononuclear cells and profiled for 420 known mature mirnas by real-time pcr. Hierarchical clustering of the data sets indicated significant differences in mirna expression between peripheral blood mononuclear cells (pbmc) and plasma microvesicles. Authors observed 71 mirnas co-expressed between microvesicles and pbmc. | |
Data imported from external databases? | No |
4 | ||
---|---|---|
First author | Rabinowits G et al. | |
Journal | Clin Lung Cancer. 10(1):42-6. | |
Title | Exosomal microrna: a diagnostic marker for lung cancer. | |
PubMed ID | 19289371 | |
Year of publication | 2009 | |
Potential biomarker role defined in the article | unknown | |
exRNA form | exosome | |
Sample | plasma | |
Sample source | - | |
Diseases, cell lines or normal status | lung cancer | |
Expression | - | |
Drug | - | |
Methods | Size exclusion chromatography and magnetic activated cell sorting using anti epithelial cell adhesion molecule (epcam)|mirvana isolation kit (ambion, austin, tx)|mirvana mirna array labeling kit (ambion)|post labeling reactive dye kit (amersham biosciences, pittsburgh, pa)|mirna microarray chips | |
Experiment Description/Results | The significant difference in total exosome and mirna levels between lung cancer patients and controls, and the similarity between the circulating exosomal mirna and the tumor-derived mirna patterns, suggest that circulating exosomal mirna might be useful as a screening test for lung adenocarcinoma. No correlation between the exosomal mirna levels and the stage of disease can be made at this point. | |
Data imported from external databases? | No |
5 | ||
---|---|---|
First author | Hanke M et al. | |
Journal | Urol Oncol. 28(6):655-61. | |
Title | A robust methodology to study urine microrna as tumor marker: microrna-126 and microrna-182 are related to urinary bladder cancer. | |
PubMed ID | 19375957 | |
Year of publication | 2010 | |
Potential biomarker role defined in the article | unknown | |
exRNA form | circulating | |
Sample | urine | |
Sample source | - | |
Diseases, cell lines or normal status | urothelial bladder cancer (bca) | |
Expression | up | |
Drug | - | |
Methods | Mirneasy kit (qiagen, hilden, germany)|quantitative reverse transcriptase-polymerase chain reaction|taqman microrna assay kits (applied biosystems, darmstadt, germany)|taqman microrna reverse transcription kit (applied biosystems, darmstadt, germany) | |
Experiment Description/Results | This study describes a novel, robust, and useful technology platform that is suitable to analyze small rnas, including novel rna-based tumor markers, in urine samples. A detailed technical analysis of this methodology provides new insights into the characteristics of urine microrna such as composition and the donor-dependent variability. | |
Data imported from external databases? | No |
6 | ||
---|---|---|
First author | Tsujiura M et al. | |
Journal | Br J Cancer. 102(7):1174-9 | |
Title | Circulating micrornas in plasma of patients with gastric cancers. | |
PubMed ID | 20234369 | |
Year of publication | 2010 | |
Potential biomarker role defined in the article | unknown | |
exRNA form | circulating | |
Sample | plasma | |
Sample source | - | |
Diseases, cell lines or normal status | gastric cancer (gc) | |
Expression | up | |
Drug | - | |
Methods | Qrt-pcr taqman microrna assay kits (applied biosystems, foster city, ca, usa)|taqman microrna reverse transcription kit (applied biosystems) | |
Experiment Description/Results | Mirnas were stable and detectable in all plasma samples, and the plasma mirna levels reflected the tumour mirnas in most cases. The levels of these mirnas were significantly reduced in post-operative samples. In large-scale analysis, the plasma concentrations of mirnas (mir-17-5p, mir-21, mir-106a, mir-106b) were significantly higher in gc patients than controls (p=0.05, 0.006, 0.008 and <0.001 respectively), whereas let-7a was lower in gc patients (p=0.002). | |
Data imported from external databases? | No |
7 | ||
---|---|---|
First author | Zampetaki A et al. | |
Journal | Circ Res. 107(6):810-7. | |
Title | Plasma microrna profiling reveals loss of endothelial mir-126 and other micrornas in type 2 diabetes. | |
PubMed ID | 20651284 | |
Year of publication | 2010 | |
Potential biomarker role defined in the article | unknown | |
exRNA form | circulating | |
Sample | plasma | |
Sample source | - | |
Diseases, cell lines or normal status | type 2 diabetes | |
Expression | down | |
Drug | - | |
Methods | Quantitative pcr|mirneasy kit (qiagen)|taqman mirna arrays a and b (all from applied biosystems) | |
Experiment Description/Results | Quantitative pcr assessment revealed lower plasma levels of mir-20b, mir-21, mir-24, mir-15a, mir-126, mir-191, mir-197, mir-223, mir-320, and mir-486 in prevalent dm, but a modest increase of mir-28-3p. Reduced mir-15a, mir-29b, mir-126, mir-223, and elevated mir-28-3p levels antedated the manifestation of disease. | |
Data imported from external databases? | No |
8 | ||
---|---|---|
First author | Asaga S et al. | |
Journal | Clin Chem. 57(1):84-91 | |
Title | Direct serum assay for microrna-21 concentrations in early and advanced breast cancer | |
PubMed ID | 21036945 | |
Year of publication | 2011 | |
Potential biomarker role defined in the article | unknown | |
exRNA form | circulating | |
Sample | serum | |
Sample source | - | |
Diseases, cell lines or normal status | Breast cancer | |
Expression | up | |
Drug | - | |
Methods | Rt-qpcr applied directly in serum (rt-qpcr-ds) assay | |
Experiment Description/Results | The assay was sensitive for detection of mir-21 in 0.625 microliter of serum from breast cancer patients. For differentiation of samples from patients with locoregional breast cancer from those from healthy donors, the odds ratio was 1.796 and the area under the curve was 0.721. In a multivariate analysis that included standard clinicopathologic prognostic factors, high circulating mir-21 concentrations correlated significantly (p < 0.001) with visceral metastasis. | |
Data imported from external databases? | No |
9 | ||
---|---|---|
First author | Xu J et al. | |
Journal | Mol Carcinog. 50(2):136-42. | |
Title | Circulating micrornas, mir-21, mir-122, and mir-223, in patients with hepatocellular carcinoma or chronic hepatitis. | |
PubMed ID | 21229610 | |
Year of publication | 2011 | |
Potential biomarker role defined in the article | unknown | |
exRNA form | circulating | |
Sample | serum | |
Sample source | - | |
Diseases, cell lines or normal status | Chronic type B hepatitis | |
Expression | up | |
Drug | - | |
Methods | Real-time quantitative rt-pcr | |
Experiment Description/Results | Mir-21, mir-122 and mir-223 are elevated in patients with hepatocellular carcinoma (hcc) or chronic hepatitis | |
Data imported from external databases? | No |
10 | ||
---|---|---|
First author | Xu J et al. | |
Journal | Mol Carcinog. 50(2):136-42. | |
Title | Circulating micrornas, mir-21, mir-122, and mir-223, in patients with hepatocellular carcinoma or chronic hepatitis. | |
PubMed ID | 21229610 | |
Year of publication | 2011 | |
Potential biomarker role defined in the article | unknown | |
exRNA form | circulating | |
Sample | serum | |
Sample source | - | |
Diseases, cell lines or normal status | hepatocellular carcinoma (hcc) | |
Expression | up | |
Drug | - | |
Methods | Real-time quantitative rt-pcr | |
Experiment Description/Results | Mir-21, mir-122 and mir-223 are elevated in patients with hepatocellular carcinoma (hcc) or chronic hepatitis | |
Data imported from external databases? | No |
11 | ||
---|---|---|
First author | Arroyo Jd et al. | |
Journal | Pnas 108(12):5003-8 | |
Title | Argonaute2 complexes carry a population of circulating micrornas independent of vesicles in human plasma. | |
PubMed ID | 21383194 | |
Year of publication | 2011 | |
Potential biomarker role defined in the article | unknown | |
exRNA form | Ago2 | |
Sample | plasma | |
Sample source | - | |
Diseases, cell lines or normal status | normal | |
Expression | - | |
Drug | - | |
Methods | Size-exclusion chromatography|mirna ready-to-use pcr, human panel i, v2.m qrt-pcr arrays (exiqon) | |
Experiment Description/Results | The majority of circulating mirnas cofractionated with protein complexes rather than with vesicles. Argonaute2 (ago2), the key effector protein of mirna-mediated silencing, was present in human plasma and eluted with plasma mirnas in size-exclusion chromatography. Furthermore, immunoprecipitation of ago2 from plasma readily recovered non vesicle-associated plasma mirnas. | |
Data imported from external databases? | No |
12 | ||
---|---|---|
First author | Arroyo Jd et al. | |
Journal | Pnas 108(12):5003-8 | |
Title | Argonaute2 complexes carry a population of circulating micrornas independent of vesicles in human plasma. | |
PubMed ID | 21383194 | |
Year of publication | 2011 | |
Potential biomarker role defined in the article | unknown | |
exRNA form | Ago2 | |
Sample | serum | |
Sample source | - | |
Diseases, cell lines or normal status | normal | |
Expression | - | |
Drug | - | |
Methods | Size-exclusion chromatography|mirna ready-to-use pcr, human panel i, v2.m qrt-pcr arrays (exiqon) | |
Experiment Description/Results | The majority of circulating mirnas cofractionated with protein complexes rather than with vesicles. Argonaute2 (ago2), the key effector protein of mirna-mediated silencing, was present in human plasma and eluted with plasma mirnas in size-exclusion chromatography. Furthermore, immunoprecipitation of ago2 from plasma readily recovered non vesicle-associated plasma mirnas. | |
Data imported from external databases? | No |
13 | ||
---|---|---|
First author | Moussay E et al. | |
Journal | Pnas 108(16):6573-8 | |
Title | Microrna as biomarkers and regulators in b-cell chronic lymphocytic leukemia. | |
PubMed ID | 21460253 | |
Year of publication | 2011 | |
Potential biomarker role defined in the article | unknown | |
exRNA form | circulating | |
Sample | plasma | |
Sample source | - | |
Diseases, cell lines or normal status | B-CLL | |
Expression | - | |
Drug | - | |
Methods | Mirneasy kit (qiagen)|taq mirna low-density array from applied biosystems | |
Experiment Description/Results | Circulating mirnas can be sensitive biomarkers for cll, because certain extracellular mirnas are present in cll patient plasma at levels significantly different from healthy controls and from patients affected by other hematologic malignancies. The levels of several of these circulating mirnas also displayed significant differences between zeta-associated protein 70 (zap-70)(+) and zap-70(-) cll. | |
Data imported from external databases? | No |
14 | ||
---|---|---|
First author | Moussay E et al. | |
Journal | Pnas 108(16):6573-8 | |
Title | Microrna as biomarkers and regulators in b-cell chronic lymphocytic leukemia. | |
PubMed ID | 21460253 | |
Year of publication | 2011 | |
Potential biomarker role defined in the article | unknown | |
exRNA form | circulating | |
Sample | plasma | |
Sample source | - | |
Diseases, cell lines or normal status | normal | |
Expression | - | |
Drug | - | |
Methods | Mirneasy kit (qiagen)|taq mirna low-density array from applied biosystems | |
Experiment Description/Results | Circulating mirnas can be sensitive biomarkers for cll, because certain extracellular mirnas are present in cll patient plasma at levels significantly different from healthy controls and from patients affected by other hematologic malignancies. The levels of several of these circulating mirnas also displayed significant differences between zeta-associated protein 70 (zap-70)(+) and zap-70(-) cll. | |
Data imported from external databases? | No |
15 | ||
---|---|---|
First author | Mittelbrunn M et al. | |
Journal | Nat Commun.2:282. | |
Title | Unidirectional transfer of microrna-loaded exosomes from t cells to antigen-presenting cells. | |
PubMed ID | 21505438 | |
Year of publication | 2011 | |
Potential biomarker role defined in the article | unknown | |
exRNA form | exosome | |
Sample | dendritic cells | |
Sample source | ts | |
Diseases, cell lines or normal status | Dendritic cells | |
Expression | - | |
Drug | - | |
Methods | Human mirna microarray kit | |
Experiment Description/Results | Unidirectional transfer of microrna-loaded exosomes from t cells to antigen-presenting cells. | |
Data imported from external databases? | Yes, ![]() |
16 | ||
---|---|---|
First author | Mittelbrunn M et al. | |
Journal | Nat Commun.2:282. | |
Title | Unidirectional transfer of microrna-loaded exosomes from t cells to antigen-presenting cells. | |
PubMed ID | 21505438 | |
Year of publication | 2011 | |
Potential biomarker role defined in the article | unknown | |
exRNA form | exosome | |
Sample | t cells | |
Sample source | cl | |
Diseases, cell lines or normal status | j77 | |
Expression | - | |
Drug | - | |
Methods | Human mirna microarray kit | |
Experiment Description/Results | Unidirectional transfer of microrna-loaded exosomes from t cells to antigen-presenting cells. | |
Data imported from external databases? | Yes, ![]() |
17 | ||
---|---|---|
First author | Zahm Am et al. | |
Journal | J Pediatr Gastroenterol Nutr. 53(1):26-33. | |
Title | Circulating microrna is a biomarker of pediatric crohn disease. | |
PubMed ID | 21546856 | |
Year of publication | 2011 | |
Potential biomarker role defined in the article | yes | |
exRNA form | circulating | |
Sample | serum | |
Sample source | - | |
Diseases, cell lines or normal status | pediatric crohn disease | |
Expression | up | |
Drug | - | |
Methods | Low-density array qrt-pcr | |
Experiment Description/Results | All of the candidate biomarker mirnas were confirmed in an independent cd sample set (n = 46). To explore the specificity of the cd-associated mirnas, they were measured in the sera of patients with celiac disease (n = 12); none were changed compared with healthy controls. | |
Data imported from external databases? | No |
18 | ||
---|---|---|
First author | Rupp Ak et al. | |
Journal | Gynecol Oncol. 122(2):437-46. | |
Title | Loss of epcam expression in breast cancer derived serum exosomes: role of proteolytic cleavage. | |
PubMed ID | 21601258 | |
Year of publication | 2011 | |
Potential biomarker role defined in the article | unknown | |
exRNA form | exosome | |
Sample | pleural effusions | |
Sample source | ts | |
Diseases, cell lines or normal status | Breast cancer | |
Expression | - | |
Drug | - | |
Methods | Rt-pcr | |
Experiment Description/Results | Loss of epcam expression in breast cancer derived serum exosomes: role of proteolytic cleavage. | |
Data imported from external databases? | Yes, ![]() |
19 | ||
---|---|---|
First author | Rupp Ak et al. | |
Journal | Gynecol Oncol. 122(2):437-46. | |
Title | Loss of epcam expression in breast cancer derived serum exosomes: role of proteolytic cleavage. | |
PubMed ID | 21601258 | |
Year of publication | 2011 | |
Potential biomarker role defined in the article | unknown | |
exRNA form | exosome | |
Sample | ascites | |
Sample source | ts | |
Diseases, cell lines or normal status | liver cirrhosis (lc) | |
Expression | - | |
Drug | - | |
Methods | Rt-pcr | |
Experiment Description/Results | Loss of epcam expression in breast cancer derived serum exosomes: role of proteolytic cleavage. | |
Data imported from external databases? | Yes, ![]() |
20 | ||
---|---|---|
First author | Rupp Ak et al. | |
Journal | Gynecol Oncol. 122(2):437-46. | |
Title | Loss of epcam expression in breast cancer derived serum exosomes: role of proteolytic cleavage. | |
PubMed ID | 21601258 | |
Year of publication | 2011 | |
Potential biomarker role defined in the article | unknown | |
exRNA form | exosome | |
Sample | malignant ascites | |
Sample source | ts | |
Diseases, cell lines or normal status | ovarian cancer | |
Expression | - | |
Drug | - | |
Methods | Rt-pcr | |
Experiment Description/Results | Loss of epcam expression in breast cancer derived serum exosomes: role of proteolytic cleavage. | |
Data imported from external databases? | Yes, ![]() |
21 | ||
---|---|---|
First author | Wei J et al. | |
Journal | Chin J Cancer. 30(6):407-14. | |
Title | Identification of plasma microrna-21 as a biomarker for early detection and chemosensitivity of non-small cell lung cancer. | |
PubMed ID | 21627863 | |
Year of publication | 2011 | |
Potential biomarker role defined in the article | yes | |
exRNA form | circulating | |
Sample | plasma | |
Sample source | - | |
Diseases, cell lines or normal status | non small cell lung cancer (nsclc) | |
Expression | up | |
Drug | platinum | |
Methods | Real-time rt-pcr | |
Experiment Description/Results | This study was to investigate whether plasma mirna-21 (mir-21) can be used as a biomarker for the early detection of non-small cell lung cancer (nsclc) and to explore its association with clinicopathologic features and sensitivity to platinum-based chemotherapy. | |
Data imported from external databases? | No |
22 | ||
---|---|---|
First author | Baggish Al et al. | |
Journal | J Physiol. 589(pt 16):3983-94. | |
Title | Dynamic regulation of circulating microrna during acute exhaustive exercise and sustained aerobic exercise training. | |
PubMed ID | 21690193 | |
Year of publication | 2011 | |
Potential biomarker role defined in the article | unknown | |
exRNA form | circulating | |
Sample | plasma | |
Sample source | - | |
Diseases, cell lines or normal status | Acute exhaustive exercise | |
Expression | up | |
Drug | - | |
Methods | Microrna extraction kit (benevbio, mission viejo, ca, usa)|rt-qpcr | |
Experiment Description/Results | Authors sought to determine whether c-mirnas are dynamically regulated in response to acute exhaustive cycling exercise and sustained rowing exercise training using a longitudinal, repeated measures study design. | |
Data imported from external databases? | No |
23 | ||
---|---|---|
First author | Baggish Al et al. | |
Journal | J Physiol. 589(pt 16):3983-94. | |
Title | Dynamic regulation of circulating microrna during acute exhaustive exercise and sustained aerobic exercise training. | |
PubMed ID | 21690193 | |
Year of publication | 2011 | |
Potential biomarker role defined in the article | unknown | |
exRNA form | circulating | |
Sample | plasma | |
Sample source | - | |
Diseases, cell lines or normal status | sustained aerobic exercise | |
Expression | - | |
Drug | - | |
Methods | Microrna extraction kit (benevbio, mission viejo, ca, usa)|rt-qpcr | |
Experiment Description/Results | Authors sought to determine whether c-mirnas are dynamically regulated in response to acute exhaustive cycling exercise and sustained rowing exercise training using a longitudinal, repeated measures study design. | |
Data imported from external databases? | No |
24 | ||
---|---|---|
First author | Tomimaru Y et al. | |
Journal | J Hepatol. 56(1):167-75. | |
Title | Circulating microrna-21 as a novel biomarker for hepatocellular carcinoma. | |
PubMed ID | 21749846 | |
Year of publication | 2012 | |
Potential biomarker role defined in the article | yes | |
exRNA form | circulating | |
Sample | plasma | |
Sample source | - | |
Diseases, cell lines or normal status | hepatocellular carcinoma (hcc) | |
Expression | up | |
Drug | - | |
Methods | Qrt-pcr | |
Experiment Description/Results | In the 10-patient group, plasma microrna-21 levels significantly diminished after surgery compared with the pre-operative values. Plasma microrna-21 level in the 126 patients with hepatocellular carcinoma was significantly higher than in patients with chronic hepatitis and healthy volunteers. | |
Data imported from external databases? | No |
25 | ||
---|---|---|
First author | Shen J et al. | |
Journal | Bmc Cancer. 11:374. | |
Title | Diagnosis of lung cancer in individuals with solitary pulmonary nodules by plasma microrna biomarkers | |
PubMed ID | 21864403 | |
Year of publication | 2011 | |
Potential biomarker role defined in the article | yes | |
exRNA form | circulating | |
Sample | plasma | |
Sample source | - | |
Diseases, cell lines or normal status | solitary pulmonary nodules (spns) | |
Expression | up | |
Drug | - | |
Methods | Mirvana mirna isolation kit (ambion, austin, tx)|qrt-pcr|taqman microrna rt kit (applied biosystems, foster city, ca) | |
Experiment Description/Results | In the training set, mir-21 and mir-210 display higher plasma expression levels, whereas mir-486-5p has lower expression level in patients with malignant spns, as compared to subjects with benign spns and healthy controls | |
Data imported from external databases? | No |
26 | ||
---|---|---|
First author | Cermelli S et al. | |
Journal | Plos One.6(8):e23937 | |
Title | Circulating micrornas in patients with chronic hepatitis c and non-alcoholic fatty liver disease. | |
PubMed ID | 21886843 | |
Year of publication | 2011 | |
Potential biomarker role defined in the article | unknown | |
exRNA form | circulating | |
Sample | serum | |
Sample source | - | |
Diseases, cell lines or normal status | Chronic type C hepatitis | |
Expression | - | |
Drug | - | |
Methods | Taqman mirna qrt-pcr assay (applied biosystems, carlsbad, ca). Reverse transcription and pcr reactions were run in triplicate in the applied biosystems 7900 system. | |
Experiment Description/Results | Serum levels of mir-34a and mir-122 may represent novel, noninvasive biomarkers of diagnosis and histological disease severity in patients with chc or nafld. | |
Data imported from external databases? | No |
27 | ||
---|---|---|
First author | Cermelli S et al. | |
Journal | Plos One.6(8):e23937 | |
Title | Circulating micrornas in patients with chronic hepatitis c and non-alcoholic fatty liver disease. | |
PubMed ID | 21886843 | |
Year of publication | 2011 | |
Potential biomarker role defined in the article | unknown | |
exRNA form | circulating | |
Sample | serum | |
Sample source | - | |
Diseases, cell lines or normal status | non-alcoholic fatty liver disease (nafld) | |
Expression | - | |
Drug | - | |
Methods | Taqman mirna qrt-pcr assay (applied biosystems, carlsbad, ca). Reverse transcription and pcr reactions were run in triplicate in the applied biosystems 7900 system. | |
Experiment Description/Results | Serum levels of mir-34a and mir-122 may represent novel, noninvasive biomarkers of diagnosis and histological disease severity in patients with chc or nafld. | |
Data imported from external databases? | No |
28 | ||
---|---|---|
First author | Wulfken Lm et al. | |
Journal | Plos One. 6(9):e25787. | |
Title | Micrornas in renal cell carcinoma: diagnostic implications of serum mir-1233 levels. | |
PubMed ID | 21984948 | |
Year of publication | 2011 | |
Potential biomarker role defined in the article | unknown | |
exRNA form | circulating | |
Sample | serum | |
Sample source | - | |
Diseases, cell lines or normal status | renal cell carcinoma (rcc) | |
Expression | up | |
Drug | - | |
Methods | Taqman low-density array qrt-pcr | |
Experiment Description/Results | Microrna levels are distinctly increased in cancer patients, although only a small subset of circulating micrornas has a tumor-specific origin. Authors identify circulating mir-1233 as a potential biomarker for rcc patients. | |
Data imported from external databases? | No |
29 | ||
---|---|---|
First author | Bihrer V et al. | |
Journal | Plos One 6(10): E26971. | |
Title | Serum microrna-21 as marker for necroinflammation in hepatitis c patients with and without hepatocellular carcinoma. | |
PubMed ID | 22066022 | |
Year of publication | 2011 | |
Potential biomarker role defined in the article | unknown | |
exRNA form | circulating | |
Sample | serum | |
Sample source | - | |
Diseases, cell lines or normal status | Chronic type C hepatitis | |
Expression | up | |
Drug | - | |
Methods | Tri reagentls (sigma-aldrich, st. louis, mo), chloroform and the mirvana rna isolation kit (ambion-abi, austin, tx)|taqman mirna reverse transcription kit | |
Experiment Description/Results | The serum mir-21 level is a marker for necroinflammatory activity, but does not differ between patients with hcv and hcv-induced hcc. | |
Data imported from external databases? | No |
30 | ||
---|---|---|
First author | Bihrer V et al. | |
Journal | Plos One 6(10): E26971. | |
Title | Serum microrna-21 as marker for necroinflammation in hepatitis c patients with and without hepatocellular carcinoma. | |
PubMed ID | 22066022 | |
Year of publication | 2011 | |
Potential biomarker role defined in the article | unknown | |
exRNA form | circulating | |
Sample | serum | |
Sample source | - | |
Diseases, cell lines or normal status | Chronic hepatitis c infection (chc)-associated hcc | |
Expression | up | |
Drug | - | |
Methods | Tri reagentls (sigma-aldrich, st. louis, mo), chloroform and the mirvana rna isolation kit (ambion-abi, austin, tx)|taqman mirna reverse transcription kit | |
Experiment Description/Results | The serum mir-21 level is a marker for necroinflammatory activity, but does not differ between patients with hcv and hcv-induced hcc. | |
Data imported from external databases? | No |
31 | ||
---|---|---|
First author | Goren Y et al. | |
Journal | Eur J Heart Fail. 14(2):147-54 | |
Title | Serum levels of micrornas in patients with heart failure. | |
PubMed ID | 22120965 | |
Year of publication | 2012 | |
Potential biomarker role defined in the article | unknown | |
exRNA form | circulating | |
Sample | serum | |
Sample source | - | |
Diseases, cell lines or normal status | Chronic systolic heart failure | |
Expression | - | |
Drug | - | |
Methods | Qrt-pcr | |
Experiment Description/Results | Elevated serum levels of specific micrornas: mir-423-5p, mir-320a, mir-22, and mir-92b, identify systolic heart failure patients and correlate with important clinical prognostic parameters. | |
Data imported from external databases? | No |
32 | ||
---|---|---|
First author | Schwarzenbach H et al. | |
Journal | Breast Cancer Res Treat. | |
Title | Diagnostic potential of pten-targeting mir-214 in the blood of breast cancer patients. | |
PubMed ID | 22350790 | |
Year of publication | 2012 | |
Potential biomarker role defined in the article | unknown | |
exRNA form | circulating | |
Sample | serum | |
Sample source | - | |
Diseases, cell lines or normal status | Breast cancer | |
Expression | up | |
Drug | - | |
Methods | Taqman microrna assays | |
Experiment Description/Results | The relative concentrations of four circulating micrornas (mir-19a, mir-20a, mir-21, and mir-214) in blood serum were measured by taqman microrna assays. Levels of preoperative serum mir-20a and mir-21 were significantly higher in patients with breast cancer and benign disease than in healthy women (p = 0.0001), but only serum mir-214 could discriminate malignant from benign tumors and healthy controls (p = 0.0001) with an area under the curve of 0.878 and 0.883 in roc analysis, respectively. | |
Data imported from external databases? | No |
33 | ||
---|---|---|
First author | Jung Ej et al. | |
Journal | Cancer. | |
Title | Plasma microrna 210 levels correlate with sensitivity to trastuzumab and tumor presence in breast cancer patients. | |
PubMed ID | 22370716 | |
Year of publication | 2011 | |
Potential biomarker role defined in the article | unknown | |
exRNA form | circulating | |
Sample | plasma | |
Sample source | - | |
Diseases, cell lines or normal status | Breast cancer | |
Expression | - | |
Drug | - | |
Methods | Reverse transcriptase-polymerase chain reaction | |
Experiment Description/Results | Circulating mir-210 levels were associated with trastuzumab sensitivity, tumor presence, and lymph node metastases. These results suggest that plasma mir-210 may be used to predict and perhaps monitor response to therapies that contain trastuzumab. | |
Data imported from external databases? | No |
34 | ||
---|---|---|
First author | Wang B et al. | |
Journal | J Cancer Res Clin Oncol. | |
Title | The expression and clinical significance of circulating microRNA-21 in serum of five solid tumors. | |
PubMed ID | 22638884 | |
Year of publication | 2012 | |
Potential biomarker role defined in the article | yes | |
exRNA form | circulating | |
Sample | serum | |
Sample source | - | |
Diseases, cell lines or normal status | Breast cancer | |
Expression | up | |
Drug | - | |
Methods | TRIzol LS Reagent (Invitrogen, Carlsbad, CA, SA)|LightCycler 480 Real-Time PCR System (Roche, USA)|FastStart Universal SYBR Green Master (Rox) mix kit (Roche, USA) | |
Experiment Description/Results | MiR-21 was significantly overexpressed in human solid cancerous serum relative to normal control, and its sensitivity and specificity were significantly higher than the currently used tumor markers. High miR-21 expression was not correlated with gender, age, clinical stage, and lymph node metastasis status. | |
Data imported from external databases? | No |
35 | ||
---|---|---|
First author | Wang B et al. | |
Journal | J Cancer Res Clin Oncol. | |
Title | The expression and clinical significance of circulating microRNA-21 in serum of five solid tumors. | |
PubMed ID | 22638884 | |
Year of publication | 2012 | |
Potential biomarker role defined in the article | yes | |
exRNA form | circulating | |
Sample | serum | |
Sample source | - | |
Diseases, cell lines or normal status | Colorectal cancer (crc) | |
Expression | up | |
Drug | - | |
Methods | TRIzol LS Reagent (Invitrogen, Carlsbad, CA, SA)|LightCycler 480 Real-Time PCR System (Roche, USA)|FastStart Universal SYBR Green Master (Rox) mix kit (Roche, USA) | |
Experiment Description/Results | MiR-21 was significantly overexpressed in human solid cancerous serum relative to normal control, and its sensitivity and specificity were significantly higher than the currently used tumor markers. High miR-21 expression was not correlated with gender, age, clinical stage, and lymph node metastasis status. | |
Data imported from external databases? | No |
36 | ||
---|---|---|
First author | Wang B et al. | |
Journal | J Cancer Res Clin Oncol. | |
Title | The expression and clinical significance of circulating microRNA-21 in serum of five solid tumors. | |
PubMed ID | 22638884 | |
Year of publication | 2012 | |
Potential biomarker role defined in the article | yes | |
exRNA form | circulating | |
Sample | serum | |
Sample source | - | |
Diseases, cell lines or normal status | lung cancer | |
Expression | up | |
Drug | - | |
Methods | TRIzol LS Reagent (Invitrogen, Carlsbad, CA, SA)|LightCycler 480 Real-Time PCR System (Roche, USA)|FastStart Universal SYBR Green Master (Rox) mix kit (Roche, USA) | |
Experiment Description/Results | MiR-21 was significantly overexpressed in human solid cancerous serum relative to normal control, and its sensitivity and specificity were significantly higher than the currently used tumor markers. High miR-21 expression was not correlated with gender, age, clinical stage, and lymph node metastasis status. | |
Data imported from external databases? | No |
37 | ||
---|---|---|
First author | Wang B et al. | |
Journal | J Cancer Res Clin Oncol. | |
Title | The expression and clinical significance of circulating microRNA-21 in serum of five solid tumors. | |
PubMed ID | 22638884 | |
Year of publication | 2012 | |
Potential biomarker role defined in the article | yes | |
exRNA form | circulating | |
Sample | serum | |
Sample source | - | |
Diseases, cell lines or normal status | Esophageal cancer | |
Expression | up | |
Drug | - | |
Methods | TRIzol LS Reagent (Invitrogen, Carlsbad, CA, SA)|LightCycler 480 Real-Time PCR System (Roche, USA)|FastStart Universal SYBR Green Master (Rox) mix kit (Roche, USA) | |
Experiment Description/Results | MiR-21 was significantly overexpressed in human solid cancerous serum relative to normal control, and its sensitivity and specificity were significantly higher than the currently used tumor markers. High miR-21 expression was not correlated with gender, age, clinical stage, and lymph node metastasis status. | |
Data imported from external databases? | No |
38 | ||
---|---|---|
First author | Wang B et al. | |
Journal | J Cancer Res Clin Oncol. | |
Title | The expression and clinical significance of circulating microRNA-21 in serum of five solid tumors. | |
PubMed ID | 22638884 | |
Year of publication | 2012 | |
Potential biomarker role defined in the article | yes | |
exRNA form | circulating | |
Sample | serum | |
Sample source | - | |
Diseases, cell lines or normal status | gastric cancer (gc) | |
Expression | up | |
Drug | - | |
Methods | TRIzol LS Reagent (Invitrogen, Carlsbad, CA, SA)|LightCycler 480 Real-Time PCR System (Roche, USA)|FastStart Universal SYBR Green Master (Rox) mix kit (Roche, USA) | |
Experiment Description/Results | MiR-21 was significantly overexpressed in human solid cancerous serum relative to normal control, and its sensitivity and specificity were significantly higher than the currently used tumor markers. High miR-21 expression was not correlated with gender, age, clinical stage, and lymph node metastasis status. | |
Data imported from external databases? | No |
39 | ||
---|---|---|
First author | Martino F et al. | |
Journal | Plos One. 7(6): E38269. | |
Title | Circulating MicroRNAs Are Not Eliminated by Hemodialysis. | |
PubMed ID | 22715378 | |
Year of publication | 2012 | |
Potential biomarker role defined in the article | unknown | |
exRNA form | circulating | |
Sample | plasma | |
Sample source | - | |
Diseases, cell lines or normal status | Acute kidney injury | |
Expression | - | |
Drug | - | |
Methods | MasterPure RNA Purification kit (Epicenter Technologies)|TaqMan microRNA Reverse Transcription kit (Applied Biosystems, Foster City, CA)|quantitative real-time PCR (qRT-PCR) via TaqMan MicroRNA Assays (Applied Biosystems) | |
Experiment Description/Results | In patients with acute kidney injury circulating microRNAs are not removed by dialysis. As only traces of miR-21 and -210 are detected in dialysate and ultrafiltrate, microRNAs in the circulation are likely to be transported by larger structures such as proteins and/or microvesicles. As miRNAs are not affected by dialysis they might be more robust biomarkers of acute kidney injury. | |
Data imported from external databases? | No |
40 | ||
---|---|---|
First author | Villar AV et al. | |
Journal | Int J Cardiol. | |
Title | Myocardial and circulating levels of microRNA-21 reflect left ventricular fibrosis in aortic stenosis patients. | |
PubMed ID | 22882958 | |
Year of publication | 2012 | |
Potential biomarker role defined in the article | yes | |
exRNA form | circulating | |
Sample | plasma | |
Sample source | - | |
Diseases, cell lines or normal status | Aortic stenosis (as) | |
Expression | up | |
Drug | - | |
Methods | ||
Experiment Description/Results | The myocardial and plasma levels of mir-21 were significantly higher in the as patients compared with the controls and correlated directly with the echocardiographic mean transvalvular gradients. | |
Data imported from external databases? | No |
41 | ||
---|---|---|
First author | Ilhan-Mutlu A et al. | |
Journal | Cancer Invest. 30(8):615-21 | |
Title | Plasma MicroRNA-21 Concentration May Be a Useful Biomarker in Glioblastoma Patients. | |
PubMed ID | 22891879 | |
Year of publication | 2012 | |
Potential biomarker role defined in the article | yes | |
exRNA form | circulating | |
Sample | plasma | |
Sample source | - | |
Diseases, cell lines or normal status | glioblastoma | |
Expression | up | |
Drug | - | |
Methods | Qrt-pcr | |
Experiment Description/Results | Microrna-21 in glioblastoma was significantly higher than controls (p = .02) and decreased significantly in 9 patients (p = .05). one patient with increasing microrna-21 developed a histopathologically proven recurrence after the second sample collection. circulating microrna-21 might be a useful biomarker in glioblastoma. | |
Data imported from external databases? | No |
42 | ||
---|---|---|
First author | Si H et al. | |
Journal | J Cancer Res Clin Oncol. | |
Title | Circulating microRNA-92a and microRNA-21 as novel minimally invasive biomarkers for primary breast cancer. | |
PubMed ID | 23052693 | |
Year of publication | 2012 | |
Potential biomarker role defined in the article | yes | |
exRNA form | circulating | |
Sample | serum | |
Sample source | - | |
Diseases, cell lines or normal status | Breast cancer | |
Expression | up | |
Drug | - | |
Methods | Qrt-pcr | |
Experiment Description/Results | The level of mir-92a was significantly lower, while mir-21 was higher, as previous reports, in tissue and serum samples of bc than that of healthy controls (p < 0.001). many mirnas expressions are altered in bc, whose expression profiling may provide a useful clue for the pathophysiological research. circulating mir-92a has potential use as novel breast cancer biomarker, which is comparable to mir-21. | |
Data imported from external databases? | No |
43 | ||
---|---|---|
First author | Jia SZ et al. | |
Journal | Hum Reprod. | |
Title | Plasma miR-17-5p, miR-20a and miR-22 are down-regulated in women with endometriosis. | |
PubMed ID | 23203215 | |
Year of publication | 2012 | |
Potential biomarker role defined in the article | unknown | |
exRNA form | circulating | |
Sample | plasma | |
Sample source | - | |
Diseases, cell lines or normal status | endometriosis | |
Expression | - | |
Drug | - | |
Methods | Qrt-pcr | |
Experiment Description/Results | Mir-17-5p, mir-20a and mir-22 were significantly down-regulated in women with endometriosis compared with controls (p = 0.011, 0.0020 and 0.0002, respectively), yielding an area under the receiver operator characteristics curve of 0.74 | |
Data imported from external databases? | No |
44 | ||
---|---|---|
First author | Ikonomidis JS et al. | |
Journal | J Thorac Cardiovasc Surg. Pii: S0022-5223(12)01571 | |
Title | Plasma biomarkers for distinguishing etiologic subtypes of thoracic aortic aneurysm disease. | |
PubMed ID | 23312977 | |
Year of publication | 2013 | |
Potential biomarker role defined in the article | yes | |
exRNA form | circulating | |
Sample | plasma | |
Sample source | - | |
Diseases, cell lines or normal status | thoracic aortic aneurysm (taa) | |
Expression | - | |
Drug | - | |
Methods | Quantitative PCR | |
Experiment Description/Results | Significant (p < .05) differences in standardized mir-1 and mir-21 abundance between bav and tav aortic tissue samples and different tissue and plasma profiles of analyte differences from normal aorta where observed between the bav and tav groups. | |
Data imported from external databases? | No |
45 | ||
---|---|---|
First author | Xie L et al. | |
Journal | Bmc Cancer. 10:591. | |
Title | Cell-free miRNAs may indicate diagnosis and docetaxel sensitivity of tumor cells in malignant effusions. | |
PubMed ID | 21029414 | |
Year of publication | 2010 | |
Potential biomarker role defined in the article | unknown | |
exRNA form | circulating | |
Sample | malignant effusions | |
Sample source | - | |
Diseases, cell lines or normal status | lung cancer | |
Expression | - | |
Drug | - | |
Methods | QRT-PCR | |
Experiment Description/Results | Authors compared the miRNA expression levels between benign and malignant effusions using a Mann-Whitney U test and found miR-24, miR-26a and miR-30d were expressed differently between the two groups (P = 0.006, 0.021 and 0.011, respectively). Cells isolated from effusions rich in cell-free miR-152 were more sensitive to docetaxel (r = 0.60, P = 0.016). | |
Data imported from external databases? | No |
46 | ||
---|---|---|
First author | Jones KL et al. | |
Journal | Clin Cancer Res. | |
Title | Plasma microRNA are disease response biomarkers in classical Hodgkin lymphoma. | |
PubMed ID | 24222179 | |
Year of publication | 2013 | |
Potential biomarker role defined in the article | yes | |
exRNA form | circulating | |
Sample | plasma | |
Sample source | - | |
Diseases, cell lines or normal status | hodgkin lymphoma (chl) | |
Expression | up | |
Drug | - | |
Methods | Qrt-pcr | |
Experiment Description/Results | Levels of mir-494, mir-1973 and mir-21 were higher in patients than control (n=20) plasma (p=0.004, p=0.007, p<0.0001, respectively). | |
Data imported from external databases? | No |
47 | ||
---|---|---|
First author | Yaman Agaoglu F et al. | |
Journal | Tumour Biol. 32(3):583-8. | |
Title | Investigation of miR-21, miR-141, and miR-221 in blood circulation of patients with prostate cancer. | |
PubMed ID | 21274675 | |
Year of publication | 2011 | |
Potential biomarker role defined in the article | yes | |
exRNA form | circulating | |
Sample | plasma | |
Sample source | - | |
Diseases, cell lines or normal status | prostate cancer | |
Expression | up | |
Drug | - | |
Methods | Real-time pcr | |
Experiment Description/Results | Analysis of mir-21, -141, and -221 in blood of pca patients reveals that mir-21 is more useful to differentiate pca patients from healthy controls, while the mir-141 was a better discriminator of metastatic pca from localized/local advanced disease. these results suggest that analysis of these mirnas might have clinical utility as a supplement to psa testing. | |
Data imported from external databases? | No |
48 | ||
---|---|---|
First author | Sanders I et al. | |
Journal | Int J Urol. 19(11):1017-25. | |
Title | Evaluation of reference genes for the analysis of serum miRNA in patients with prostate cancer, bladder cancer and renal cell carcinoma. | |
PubMed ID | 22788411 | |
Year of publication | 2012 | |
Potential biomarker role defined in the article | unknown | |
exRNA form | circulating | |
Sample | serum | |
Sample source | - | |
Diseases, cell lines or normal status | prostate cancer | |
Expression | - | |
Drug | - | |
Methods | Quantitative real-time pcr | |
Experiment Description/Results | The level of mir-21 was similar in cancer patients and healthy controls, irrespective of the normalization strategy. | |
Data imported from external databases? | No |
49 | ||
---|---|---|
First author | Shen J et al. | |
Journal | Prostate. 72(13):1469-77. | |
Title | Dysregulation of circulating microRNAs and prediction of aggressive prostate cancer. | |
PubMed ID | 22298119 | |
Year of publication | 2012 | |
Potential biomarker role defined in the article | yes | |
exRNA form | circulating | |
Sample | plasma | |
Sample source | - | |
Diseases, cell lines or normal status | prostate cancer | |
Expression | up | |
Drug | - | |
Methods | Qrt-pcr | |
Experiment Description/Results | These preliminary data suggest that altered plasma mirnas may be useful predictors to distinguish pca patients with varied aggressiveness. further larger studies to validate this promising finding are warranted. | |
Data imported from external databases? | No |
50 | ||
---|---|---|
First author | Watahiki A et al. | |
Journal | Int J Mol Sci. 14(4):7757-70. | |
Title | Plasma miRNAs as Biomarkers to Identify Patients with Castration-Resistant Metastatic Prostate Cancer. | |
PubMed ID | 23574937 | |
Year of publication | 2013 | |
Potential biomarker role defined in the article | yes | |
exRNA form | circulating | |
Sample | plasma | |
Sample source | - | |
Diseases, cell lines or normal status | prostate cancer | |
Expression | up | |
Drug | - | |
Methods | Exiqon miRNA qPCR panel|qRT-PCR | |
Experiment Description/Results | Authors identified 63 miRNAs upregulated in mCRPC versus localized PCa, while only four were downregulated. Pearson's correlation analysis revealed two highly correlated groups: one consisting of miR-141, miR375 and miR-200c and the other including miR151-3p, miR423-3p, miR-126, miR152 and miR-21. A third group, containing miR-16 and miR-205, showed less correlation. One miRNA from each group (miR-141, miR151-3p and miR-16) was used for logistic regression analysis and proved to increase the sensitivity of the prostate-specific antigen (PSA) test alone. | |
Data imported from external databases? | No |
51 | ||
---|---|---|
First author | Zhang HL et al. | |
Journal | Prostate. 71(3):326-31. | |
Title | Serum miRNA-21: elevated levels in patients with metastatic hormone-refractory prostate cancer and potential predictive factor for the efficacy of docetaxel-based chemotherapy. | |
PubMed ID | 20842666 | |
Year of publication | 2011 | |
Potential biomarker role defined in the article | yes | |
exRNA form | circulating | |
Sample | serum | |
Sample source | - | |
Diseases, cell lines or normal status | prostate cancer | |
Expression | up | |
Drug | docetaxel | |
Methods | Taqman real-time pcr | |
Experiment Description/Results | Serum mir-21 levels are elevated in hrpc patients, especially in those resistant to docetaxel-based chemotherapy. it may be applicable as a marker to indicate the transformation to hormone refractory disease, and a potential predictor for the efficacy of docetaxel-based chemotherapy. | |
Data imported from external databases? | No |
52 | ||
---|---|---|
First author | Zhang J et al. | |
Journal | Chin Med J (engl). 127(12):2212-7. | |
Title | Inflammation induced-endothelial cells release angiogenesis associated-microRNAs into circulation by microparticles. | |
PubMed ID | 24931230 | |
Year of publication | 2014 | |
Potential biomarker role defined in the article | unknown | |
exRNA form | microparticle | |
Sample | atherosclerotic plaques | |
Sample source | endothelial cells | |
Diseases, cell lines or normal status | Atherosclerosis | |
Expression | up | |
Drug | - | |
Methods | Real-time pcr | |
Experiment Description/Results | By comparing microparticles isolated from human atherosclerotic plaques with an active inflammatory phenotype (n = 9) and those from normal vascular tissues (n = 9), we found levels of annexin v(+) microparticles and annexin v(+) cd144(+) microparticles were significantly increased in plaques and angiogenesis associated micrornas (106b, 25, 92a and 21) were also significantly increased in microparticles from plaques. inflammation could induce endothelial cells to release angiogenesis associated micrornas into circulation, causing higher levels of circulating endothelial cells derived micrornas in atherosclerosis. | |
Data imported from external databases? | No |
53 | ||
---|---|---|
First author | Basati G et al. | |
Journal | Med Oncol. 31(10):205. | |
Title | Elevated level of microRNA-21 in the serum of patients with colorectal cancer. | |
PubMed ID | 25178939 | |
Year of publication | 2014 | |
Potential biomarker role defined in the article | yes | |
exRNA form | circulating | |
Sample | serum | |
Sample source | - | |
Diseases, cell lines or normal status | Colorectal cancer (crc) | |
Expression | up | |
Drug | - | |
Methods | Qrt-pcr | |
Experiment Description/Results | Increased levels of serum mir-21 were associated with clinical stages of tumors in the patients (p=0.01). these results indicated that serum mir-21 levels could serve as a reliable diagnostic and prognostic biomarker for colorectal adenocarcinoma. | |
Data imported from external databases? | No |
54 | ||
---|---|---|
First author | Muller V et al. | |
Journal | Breast Cancer Res Treat. 147(1):61-8. | |
Title | Changes in serum levels of miR-21, miR-210, and miR-373 in HER2-positive breast cancer patients undergoing neoadjuvant therapy: a translational research project within the Geparquinto trial. | |
PubMed ID | 25086636 | |
Year of publication | 2014 | |
Potential biomarker role defined in the article | yes | |
exRNA form | circulating | |
Sample | serum | |
Sample source | - | |
Diseases, cell lines or normal status | Breast cancer | |
Expression | up | |
Drug | trastuzumab | |
Methods | Taqman human microrna arrays | |
Experiment Description/Results | Authors demonstrate a specific influence of neoadjuvant therapy on the serum levels of mir-21, mir-210, and mir-373 in breast cancer patients together with a prognostic value of mir-21. | |
Data imported from external databases? | No |
55 | ||
---|---|---|
First author | Jiang R et al. | |
Journal | Part Fibre Toxicol. 11(1):71. | |
Title | Short-term diesel exhaust inhalation in a controlled human crossover study is associated with changes in DNA methylation of circulating mononuclear cells in asthmatics. | |
PubMed ID | 25487561 | |
Year of publication | 2014 | |
Potential biomarker role defined in the article | unknown | |
exRNA form | circulating | |
Sample | blood | |
Sample source | - | |
Diseases, cell lines or normal status | Asthma | |
Expression | up | |
Drug | - | |
Methods | ||
Experiment Description/Results | Authors demonstrated that short-term exposure to diesel exhaust resulted in dna methylation changes at cpg sites residing in genes involved in inflammation and oxidative stress response, repetitive elements, and microrna. | |
Data imported from external databases? | No |
56 | ||
---|---|---|
First author | Muller V et al. | |
Journal | Breast Cancer Res Treat. 147(1):61-8. | |
Title | Changes in serum levels of miR-21, miR-210, and miR-373 in HER2-positive breast cancer patients undergoing neoadjuvant therapy: a translational research project within the Geparquinto trial. | |
PubMed ID | 25086636 | |
Year of publication | 2014 | |
Potential biomarker role defined in the article | yes | |
exRNA form | circulating | |
Sample | serum | |
Sample source | - | |
Diseases, cell lines or normal status | Breast cancer | |
Expression | up | |
Drug | lapatinib | |
Methods | Taqman microrna assays | |
Experiment Description/Results | Authors demonstrate a specific influence of neoadjuvant therapy on the serum levels of mir-21, mir-210, and mir-373 in breast cancer patients together with a prognostic value of mir-21. | |
Data imported from external databases? | No |
57 | ||
---|---|---|
First author | Kim Y et al. | |
Journal | Plos One. 9(2):e86933. | |
Title | Serum microRNA-21 as a potential biomarker for response to hypomethylating agents in myelodysplastic syndromes. | |
PubMed ID | 24503739 | |
Year of publication | 2014 | |
Potential biomarker role defined in the article | yes | |
exRNA form | circulating | |
Sample | serum | |
Sample source | - | |
Diseases, cell lines or normal status | myelodysplastic syndromes (mds) | |
Expression | down | |
Drug | hypomethylating agents (hmas) | |
Methods | Mirvana paris kit (ambion inc., austin, tx)|qrt-pcr | |
Experiment Description/Results | Serum mir-21 is a potential biomarker of epigenetic therapy in mds patients. | |
Data imported from external databases? | No |
58 | ||
---|---|---|
First author | Ma GJ et al. | |
Journal | Asian Pac J Cancer Prev. 14(12):7551-4. | |
Title | Plasma post-operative miR-21 expression in the prognosis of gastric cancers. | |
PubMed ID | 24460332 | |
Year of publication | 2013 | |
Potential biomarker role defined in the article | yes | |
exRNA form | circulating | |
Sample | plasma | |
Sample source | - | |
Diseases, cell lines or normal status | gastric cancer (gc) | |
Expression | down | |
Drug | - | |
Methods | Qrt-pcr | |
Experiment Description/Results | The results suggested plasma mir-21 could be a novel potential biomarker for gc prognosis and evaluation of surgery outcomes, especially in patients without a family history. | |
Data imported from external databases? | No |
59 | ||
---|---|---|
First author | Song WF et al. | |
Journal | Asian Pac J Cancer Prev. 14(12):7529-36. | |
Title | MiR-21 upregulation induced by promoter zone histone acetylation is associated with chemoresistance to gemcitabine and enhanced malignancy of pancreatic cancer cells. | |
PubMed ID | 24460329 | |
Year of publication | 2013 | |
Potential biomarker role defined in the article | yes | |
exRNA form | circulating | |
Sample | serum | |
Sample source | - | |
Diseases, cell lines or normal status | pancreatic ductal adenocarcinoma (pdac) | |
Expression | up | |
Drug | gemcitabine | |
Methods | Real-time pcr | |
Experiment Description/Results | Serum mir-21 levels were increased in gemcitabine- resistant pdac patients compared with gemcitabine-sensitive subjects. | |
Data imported from external databases? | No |
60 | ||
---|---|---|
First author | Ren W et al. | |
Journal | Biomarkers. 19(7):590-6. | |
Title | Circulating microRNA-21 (MIR-21) and phosphatase and tensin homolog (PTEN) are promising novel biomarkers for detection of oral squamous cell carcinoma. | |
PubMed ID | 25174622 | |
Year of publication | 2014 | |
Potential biomarker role defined in the article | yes | |
exRNA form | circulating | |
Sample | blood | |
Sample source | - | |
Diseases, cell lines or normal status | oral squamous cell carcinoma (oscc) | |
Expression | up | |
Drug | - | |
Methods | E.z.n.a. blood rna kit|quantitative real-time reverse transcriptionpolymerase chain reaction | |
Experiment Description/Results | Authors demonstrate that circulating mir-21 and pten might represent new complementary tumour markers for oscc. | |
Data imported from external databases? | No |
61 | ||
---|---|---|
First author | Chen W et al. | |
Journal | Eur J Haematol. 92(5):407-12. | |
Title | Clinical significance and detection of microRNA-21 in serum of patients with diffuse large B-cell lymphoma in Chinese population. | |
PubMed ID | 24400911 | |
Year of publication | 2014 | |
Potential biomarker role defined in the article | yes | |
exRNA form | circulating | |
Sample | serum | |
Sample source | - | |
Diseases, cell lines or normal status | Diffuse large b-cell lymphoma (dlbcl) | |
Expression | up | |
Drug | - | |
Methods | Fluorescent quantitative pcr | |
Experiment Description/Results | Authors show that mir-21 may be served as a biomarker in early diagnosis, genotyping, treatment options, and prognosis estimating of chinese dlbcl. | |
Data imported from external databases? | No |
62 | ||
---|---|---|
First author | Gao J et al. | |
Journal | Chin J Cancer Res. 25(6):743-8. | |
Title | Clinical significance of serum miR-21 in breast cancer compared with CA153 and CEA. | |
PubMed ID | 24385703 | |
Year of publication | 2013 | |
Potential biomarker role defined in the article | yes | |
exRNA form | circulating | |
Sample | serum | |
Sample source | - | |
Diseases, cell lines or normal status | Breast cancer | |
Expression | up | |
Drug | - | |
Methods | Real-time pcr | |
Experiment Description/Results | Authors show that serum mir-21 may be a potential diagnostic indicator for bc, especially for the early stage. | |
Data imported from external databases? | No |
63 | ||
---|---|---|
First author | Seeliger C et al. | |
Journal | J Bone Miner Res. 29(8):1718-28. | |
Title | Five freely circulating miRNAs and bone tissue miRNAs are associated with osteoporotic fractures. | |
PubMed ID | 24431276 | |
Year of publication | 2014 | |
Potential biomarker role defined in the article | yes | |
exRNA form | circulating | |
Sample | serum | |
Sample source | - | |
Diseases, cell lines or normal status | osteoporosis | |
Expression | up | |
Drug | - | |
Methods | Mirna pcr array | |
Experiment Description/Results | Authors identified 9 mirnas, namely mir-21, mir-23a, mir-24, mir-93, mir-100, mir-122a, mir-124a, mir-125b, and mir-148a, that were significantly upregulated in the serum of patients with osteoporosis. | |
Data imported from external databases? | No |
64 | ||
---|---|---|
First author | Song J et al. | |
Journal | Oncol Lett. 6(6):1733-1737. | |
Title | Serum microRNA-21 levels are related to tumor size in gastric cancer patients but cannot predict prognosis. | |
PubMed ID | 24260069 | |
Year of publication | 2013 | |
Potential biomarker role defined in the article | yes | |
exRNA form | circulating | |
Sample | serum | |
Sample source | - | |
Diseases, cell lines or normal status | gastric cancer (gc) | |
Expression | up | |
Drug | - | |
Methods | Quantitative PCR | |
Experiment Description/Results | Authors suggest that serum mir-21 could be exploited as a practical biomarker for monitoring tumor burden in patients with gc. | |
Data imported from external databases? | No |
65 | ||
---|---|---|
First author | He QF et al. | |
Journal | Biomed Environ Sci. 2016 May;29(5):385-9 | |
Title | Circulating MicroRNA-21 is Downregulated in Patients with Metabolic Syndrome. | |
PubMed ID | 27353714 | |
Year of publication | 2016 | |
Potential biomarker role defined in the article | yes | |
exRNA form | circulating | |
Sample | plasma | |
Sample source | - | |
Diseases, cell lines or normal status | metabolic syndrome (mets) | |
Expression | down | |
Drug | - | |
Methods | Qrt-pcr | |
Experiment Description/Results | Expression levels of mir-21 were significantly decreased in the circulation of mets subjects (or=0.52, 95% ci: 0.29-0.92) compared with that of non-mets subjects. body mass index (bmi) and the number of mets components had a negative correlation with the level of mir-21, whereas age was inversely related to the level of mir-21. no significant difference was detected in mir-21 levels between the sexes (p=0.056). mir-21 might be a negative regulating factor in mets. | |
Data imported from external databases? | No |
66 | ||
---|---|---|
First author | Montagnana M et al. | |
Journal | Clin Lab. 62(5):967-70 | |
Title | Plasma Expression Levels of Circulating miR-21 are not Useful for Diagnosing and Monitoring Colorectal Cancer. | |
PubMed ID | 27349026 | |
Year of publication | 2016 | |
Potential biomarker role defined in the article | unknown | |
exRNA form | circulating | |
Sample | plasma | |
Sample source | - | |
Diseases, cell lines or normal status | Colorectal cancer (crc) | |
Expression | - | |
Drug | - | |
Methods | Quantitative reverse transcription polymerase chain reaction (rt-qpcr) | |
Experiment Description/Results | These results do not support the hypothesis that circulating mir-21 expression is increased in adenoma-carcinoma-advanced carcinoma sequence. accordingly, plasma mir-21 assessment does not appear to be a useful biomarker for diagnosing and staging crc. | |
Data imported from external databases? | No |
67 | ||
---|---|---|
First author | Chien HY et al. | |
Journal | Int J Med Sci. 13(6):457-65 | |
Title | Differential microRNA Profiles Predict Diabetic Nephropathy Progression in Taiwan. | |
PubMed ID | 27279796 | |
Year of publication | 2016 | |
Potential biomarker role defined in the article | yes | |
exRNA form | circulating | |
Sample | serum | |
Sample source | - | |
Diseases, cell lines or normal status | diabetic nephropathy (dn) | |
Expression | up | |
Drug | - | |
Methods | Rt-pcr | |
Experiment Description/Results | The levels of mir-21, mir-29a and mir-192 were significantly enriched in the overt proteinuria group compared with microalbuminuria and/or overt proteinuria groups. it was shown that only mir-21 level was significantly up-regulated in low-egfr group compared with high-egfr patients. | |
Data imported from external databases? | No |
68 | ||
---|---|---|
First author | Zhang L et al. | |
Journal | Int J Gynecol Cancer. 26(5):810-6 | |
Title | Circulating MicroRNA-21 Is Involved in Lymph Node Metastasis in Cervical Cancer by Targeting RASA1. | |
PubMed ID | 27101583 | |
Year of publication | 2016 | |
Potential biomarker role defined in the article | yes | |
exRNA form | circulating | |
Sample | serum | |
Sample source | - | |
Diseases, cell lines or normal status | Cervical cancer | |
Expression | up | |
Drug | - | |
Methods | ||
Experiment Description/Results | Circulating mir-21 in serum could be a promising biomarker in auxiliary diagnosis of lymph node metastasis in cervical cancer, and inhibition of mir-21/rasa1 axis could be a possible strategy to restrain migration of cervical cancer. | |
Data imported from external databases? | No |
69 | ||
---|---|---|
First author | Collino F et al. | |
Journal | Plos One. 5(7):e11803 | |
Title | Microvesicles derived from adult human bone marrow and tissue specific mesenchymal stem cells shuttle selected pattern of miRNAs. | |
PubMed ID | 20668554 | |
Year of publication | 2010 | |
Potential biomarker role defined in the article | unknown | |
exRNA form | microvesicle | |
Sample | mesenchymal stem cells | |
Sample source | ts | |
Diseases, cell lines or normal status | Mesenchymal stem cells - Normal | |
Expression | - | |
Drug | - | |
Methods | Rt-pcr|Differential centrifugation|Ultracentrifugation | |
Experiment Description/Results | Microvesicles derived from adult human bone marrow and tissue specific mesenchymal stem cells shuttle selected pattern of miRNAs | |
Data imported from external databases? | Yes, ![]() |
70 | ||
---|---|---|
First author | Skog J et al. | |
Journal | Nat Cell Biol. 10(12):1470-6 | |
Title | Glioblastoma microvesicles transport RNA and proteins that promote tumour growth and provide diagnostic biomarkers. | |
PubMed ID | 19011622 | |
Year of publication | 2008 | |
Potential biomarker role defined in the article | unknown | |
exRNA form | microvesicle | |
Sample | glioblastoma cells | |
Sample source | ts | |
Diseases, cell lines or normal status | Glioblastoma cells | |
Expression | - | |
Drug | - | |
Methods | Rt-pcr|Differential centrifugation|Ultracentrifugation|Filtration | |
Experiment Description/Results | Glioblastoma microvesicles transport RNA and proteins that promote tumour growth and provide diagnostic biomarkers | |
Data imported from external databases? | Yes, ![]() |
71 | ||
---|---|---|
First author | Yuan A et al. | |
Journal | Plos One. 4(3):e4722 | |
Title | Transfer of microRNAs by embryonic stem cell microvesicles. | |
PubMed ID | 19266099 | |
Year of publication | 2009 | |
Potential biomarker role defined in the article | unknown | |
exRNA form | microvesicle | |
Sample | embryonic stem cells | |
Sample source | ts | |
Diseases, cell lines or normal status | Embryonic stem cells | |
Expression | - | |
Drug | - | |
Methods | Rt-pcr|Differential centrifugation | |
Experiment Description/Results | Transfer of microRNAs by embryonic stem cell microvesicles | |
Data imported from external databases? | Yes, ![]() |